S100A11 and precursor B-cell acute lymphoblastic leukemia: As shown in Figures 4B–F, the gene expression of BIK, HOXA7, S100A10 and S100A11 were significantly higher in B-ALL patients who relapsed within 24 months (both p < 0.05).